Log in
Enquire now
‌

US Patent 7605238 Human CTLA-4 antibodies and their uses

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7605238
Patent Inventor Names
Tibor P. Keler0
Alan J. Korman0
Edward L. Halk0
Nils Lonberg0
Yashwant M. Deo0
Date of Patent
October 20, 2009
Patent Application Number
09948939
Date Filed
September 7, 2001
Patent Citations Received
0
‌
US Patent 12084655 Packaging oligonucleotides into virus-like particles
0
‌
US Patent 11707056 Animals, repertoires and methods
0
‌
US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 11767361 Method of treating lung cancer
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
...
Patent Primary Examiner
‌
Ilia Ouspenski
Patent abstract

The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7605238 Human CTLA-4 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.